2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Keyword Index<br />
hydrocephaly: P05.11<br />
Hydrops fetalis: P12.093<br />
Hyperandrogenism: P09.059<br />
hypercholesterolaemia: P17.46<br />
Hypercholesterolemia: P17.47, P17.49<br />
Hyperechogenic fetal bowel: P02.127<br />
hyperferritinemia: P12.094<br />
hyperhomocysteinaemia: P17.36<br />
Hyper-IgD: P12.059<br />
hypermethylation: P03.195<br />
hypernasal speech: P02.051<br />
hypertension: P09.108, P17.04, P17.13,<br />
P17.16, P17.28, P17.29<br />
Hypertriglyceridemia: P08.09<br />
Hypertrophic Cardiomyopathy: C01.6,<br />
C13.4, C18.6, P13.12, P16.11, P16.12,<br />
P16.13, P16.16, P16.23, P16.24, P16.25,<br />
P16.26, P16.27, S03.2<br />
hypertrophic: S03.3<br />
hyperuricemia: P08.36<br />
Hypoacusia: P10.35<br />
hypodontia: P02.087<br />
hypomelanosis <strong>of</strong> Ito: P03.143<br />
hypothenar muscle atrophy: P02.016<br />
hypotrichosis: P02.052, P10.44<br />
i<br />
I/D polymorphism: P08.08<br />
IBD: P09.053<br />
I-cell disease: P13.37<br />
ICSI: P04.06, P04.27<br />
Identity: C09.2<br />
idiopathic chronic pancreatitis: P12.095<br />
idiopathic neonatal epilepsy: P17.70<br />
idiopathic ventricular fibrillation: C13.1<br />
Idiopathic: P02.069<br />
idiopatic hirsutism: P13.27<br />
I-FISH: P07.08<br />
IFT80 gene: P02.164<br />
IGA nephropathy: P12.164<br />
IgE: P09.054<br />
IGF: P06.179<br />
IGF-I: P10.45<br />
IgG: P12.061<br />
IGH: P06.199<br />
Iintra-intronic minisatellite: P11.061<br />
Ikaros: C06.6<br />
IKBKG: P02.054, P12.096<br />
IL10 (-1082G/A): P06.047<br />
IL-10: P10.49<br />
IL-1β: P06.037<br />
IL2 / IL2RA: P09.079<br />
IL23R: P10.46<br />
IL2RA: P09.009<br />
image analysis: P03.052<br />
Imatinib treatment: P06.189<br />
immunogenetic: P04.24<br />
immunosuppressant: P08.56<br />
Imprinting: C15.2, P04.07, P04.29<br />
imputation: C05.6<br />
In Best Vitelliform Macular Dystrophy:<br />
P02.053<br />
in men: P03.032<br />
Inborn Errors <strong>of</strong> Metabolism: P10.47<br />
inbreeding coefficient: P10.41<br />
incidence: P02.163, P10.47, P13.11,<br />
P13.39<br />
incomplete penetrance: C02.3<br />
Incontinentia pigmenti: P02.054, P12.096,<br />
P12.115<br />
Indigenous populations: P10.60<br />
individual DNA data bank: P01.18<br />
Infantile polyposis: P06.048<br />
infantile Pompe disease: P14.08<br />
infection: P02.027<br />
Infections-virology: P12.056<br />
infertile women: P03.031<br />
infertiliry: P03.190<br />
infertility: C07.3, P03.032, P03.037,<br />
P03.197, P04.03, P04.08, P04.09, P04.20<br />
inflammation: P09.055<br />
inflammatory bowel disease: P09.056,<br />
P09.057<br />
Inflammatory bowel diseases: P09.058<br />
INHERITED CARDIAC ARRHYTHMIAS:<br />
P16.20<br />
inherited cardiac diseases: P16.05<br />
inherited organic acidurias: P13.28<br />
Innate immunity: C08.3<br />
inner ear development: C14.1<br />
Innovations: P15.05<br />
INPP5E: C03.1<br />
INS: P17.02<br />
Insulin Receptor: P17.10<br />
insulin resistance: P17.06<br />
Insulin signalling: PL2.3, S14.3<br />
insulin: P12.097<br />
Insuline resistance: P09.059<br />
Integration: P14.11<br />
Intellectually Handicapped: P03.033<br />
Intelligent Quotient;: P03.034<br />
interacting proteins: P11.017<br />
interaction: P10.36<br />
interferon regulatory factor 5: P09.080<br />
intergenic interactions: P09.107<br />
interindividual variability: P03.014<br />
interleukin-10: P06.172<br />
Interleukin-7 receptor α: P09.081<br />
Intermediate allele: P03.153<br />
International Classification <strong>of</strong> Diseases<br />
(ICD 10): P01.22<br />
international consensus: P06.049<br />
Internet Technologies: P01.08<br />
Interpopulation Differences: P10.21<br />
Interstitial Cajal Cells: P11.062<br />
Intracranial calcification: C08.3<br />
intrahepatic cholestasis <strong>of</strong> pregnancy:<br />
P09.060<br />
intrinsic attachment: P09.083<br />
intronic mutation: P16.09<br />
Intronic mutations: P02.147<br />
inv 1p: P03.127<br />
invasive prenatal diagnostics: C07.6<br />
Inversion (9): P05.13<br />
inversion 18: P03.146<br />
Inversion Y: P03.035<br />
inversion: P03.190, P08.62<br />
inverted duplication: P03.036, P03.121,<br />
P06.157<br />
IRAK3: P09.061, P10.48<br />
Iran: P01.14, P02.171, P02.173, P02.175,<br />
P02.176, P02.178, P03.016, P06.035,<br />
P06.140, P08.34, P08.37, P08.38,<br />
P08.66, P12.030, P12.057, P12.075,<br />
P16.34, P16.37<br />
Iranian population: P02.182, P10.77,<br />
P12.155<br />
Iranian: P06.043<br />
Iraq, Iran: P10.14<br />
IRF5: P09.120<br />
IRF6 gene: P09.027<br />
IRIDA: P12.098<br />
irinotecan: P06.097<br />
iron: P09.062, P12.098<br />
irritable bowel syndrome: P09.063<br />
ischemia: P11.122<br />
ischemic: P09.116<br />
islamic republic <strong>of</strong> iran: P10.75<br />
isochromosome Xp: P07.06<br />
isochromosome Xq: P03.038<br />
isochromosome: P03.128, P05.38<br />
isolate population: P16.04<br />
Ist and 2nd trimester screening: P05.02<br />
IT15 gene: P12.090<br />
ITPA: P06.176<br />
ITPR-1 gene: P12.146<br />
ITPR1: P12.145<br />
IVSI-II(T>C): P12.099<br />
IVSII-I: P12.001<br />
IVSII-nt1 Mutation: P02.173<br />
J<br />
Jacobsen syndrome: P03.129<br />
JAG1: P12.007<br />
JAK1: P06.177<br />
JAK2: P09.064<br />
Japanese: P08.27<br />
JARID1C: P02.198
Change language